Content of the study

Available languages

MARKET OVERVIEW

1.1 Definitions and market overview

The market for aesthetic medicine and surgery in France comprises several very distinct segments [La Roche Posay; Le Figaro Santé] :

  • Plastic surgery, body reshaping techniques by means of surgical procedures to correct a morphological anomaly or the external appearance of a patient's body;
  • Aesthetic medicine, which represents all the advice, care and non-surgical treatments intended to improve the aesthetic appearance of a patient;
  • Cosmeceuticals, products that are halfway between cosmetics and medicine, which contain active ingredients for a specific dermatological treatment (wrinkles, dark circles, etc.).

Aesthetic surgery is therefore exclusively concerned with operations on the patient's body, such as breast surgery, the most popular procedure. Aesthetic medicine, on the other hand, can be performed by general practitioners or specialists. The vast majority of aesthetic medicine procedures involve injections under the skin, for example to reduce wrinkles. Cosmeceuticals are most frequently used to correct skin aging, although their effectiveness has yet to be proven.

The global market for cosmetic surgery and medicine is growing rapidly, driven in particular by the dynamism of the Asian regions, which are currently the main focus of global demand. However, the market remains largely dominated by the United States and Brazil. This growth is partly due to the development of injectable substances, but also to the renewal of equipment and technologies required for operations.

The French market is also growing, in particular due to the increasing popularity of so-called "non-invasive" aesthetic medicine methods, which are halfway located between medical treatment and cosmetic surgery and practiced by beauty salons, to the detriment of surgical procedures in clinics whose popularity has been affected by numerous scandals.

In France, more than one million people have already had recourse to cosmetic surgery, and the legal framework plays a predominant role in the supervision of the market and the authorization of certain practices. It is therefore crucial to understand the major dynamics of the market [France Tv].

 

1.2 A rapidly growing global market

The global aesthetic medicine market was valued at $**.* billion in **** and is expected to grow at a CAGR of *.*% by ****. Innovation in aesthetic devices over the past decade has led to growth in demand for aesthetic treatments.

The introduction of technically advanced products, such as non-invasive body contouring systems using controlled ...

1.3 A French market increasingly focused on non-invasive aesthetic medicine

In France, in ****, the number of cosmetic surgery and aesthetic medicine procedures amounted to ***,***, placing France in the eighth place of the global cosmetic medicine and surgery market. The number of women who have had cosmetic surgery in France was **% of the population, which represents approximately *.* million women [***].

By estimating that ...

ANALYSIS OF THE DEMAND

2.1 A demand driven by a small share of the population

In France, the demand of the aesthetic market has been growing continuously for several decades thanks to different socio-demographic factors such as the ageing of the population, the growing importance of physical appearance in French society, a steadily increasing female population and the expansion of the market to include men. However, ...

MARKET STRUCTURE

3.1 A market structured around equipment manufacturers and practitioners

There are two main types of players in the medical and cosmetic surgery market: upstream manufacturers of equipment for aesthetic purposes, and downstream practitioners or care establishments.

*) Equipment manufacturers

The French market of manufacturers is characterized by a very important specialization, because of the technology and the demanding costs of ...

3.2 Production of medical and cosmetic surgery equipment

The production of aesthetic devices includes the manufacture of breast prostheses, injectables, cosmeceuticals and other equipment. As the aesthetic market requires high entry costs and advanced technology, most manufacturers are specialized in the production of one of these segments.

As the main players in the market are international groups, the majority ...

3.3 A trend towards diversification

The actors of the distribution market

The distribution market of aesthetic products includes three main types of actors: the group in charge of production, a subsidiary of the group specialized in distribution and finally a wholesaler specialized in the distribution of aesthetic medicine and surgery products.

The integrated model where the ...

3.4 Multi-channel distribution and increasing autonomy of end consumers

The development of various distribution channels has pushed manufacturers to orient their distribution towards a multi-channel strategy. The main distribution channels that are growing today are selective perfumeries, web merchants, mail order and large-scale distributors specialized in home appliances. For example, Talika's home devices have been sold since **** at Marionnaud as ...

ANALYSIS OF THE OFFER

4.1 Typology of aesthetic medicine services

Aesthetic medicine

In France, in ****, aesthetic medicine was mostly composed of injection procedures (***) [***].

Wrinkle-filling injections, on the other hand, are much less regulated, allowing more than *** brands to compete on the French market, held by about ** manufacturers, such as Allergan or Ateis.

In **** in France, according to the IFOP survey, hair ...

4.2 Prices for aesthetic medicine services

According to the French Association of Aesthetic and Anti-Aging Medicine (***), the average rates for various aesthetic medicine procedures on the silhouette at the end of **** were as follows:

Source: ****

For cosmetic surgery services on the body, we obtain the following results:

Source: ****

The rates for cosmetic surgery on the face and ...

REGULATION

5.1 Stricter regulations after the PIP scandal

The medical and cosmetic surgery market continues to grow despite the PIP case, which began in **** when the prostheses were withdrawn from the market following the first case of cancer detected because of anomalies in the product. The certifying body of these prostheses, TÜV, was sentenced in **** to pay compensation ...

POSITIONING OF THE ACTORS

6.1 Segmentation

Pharmaceutical companies:

Allergan plc Galderma Merz Pharmaceuticals

Dermo-cosmetic laboratories :

Pierre Fabre La Roche-Possay Filorga Cosmetics Lierac

Manufacturers of medical and surgical equipment :

Laboratoires Sebbin Arion Syneron Candela Deleo

  • Allergan plc
  • Galderma
  • Merz Pharmaceuticals
  • Pierre Fabre
  • La Roche-Posay
  • Filorga Cosmétiques
  • Lierac (Ales Groupe)
  • Laboratoires Sebbin
  • Arion
  • Syneron Candela
  • Deleo

To keep reading, buy the full research

What is in this market study?

  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What are the latest trends in this market?
  • What is the positioning of companies in the value chain?
  • How do companies in the market differ from each other?
  • Access company mapping and profiles.
  • Data from several dozen databases

  • This market study is available online and in pdf format (30 p.)
  • Consult an example PDF or online
  • Recent reviews ★★★★☆ 

Buy a pack and get an immediate discount

Pack 5 études (-15%) - France

378€

  • 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
  • Conservez -15% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez les conditions du pack et de remboursement des crédits non consommés.

Inclus dans ce pack: This study (The aesthetic medicine market - France) + 4 other studies of your choice

Buy the 5 Study Pack 378€

Method

Data
Analysts 1 sector analyzed
in 40 pages
Method
Control

Analysts

  • Top Universities
  • Expert opinion

Data

  • Databases
  • Press
  • Company reports

Control

  • Continuously updated
  • Permanent watch

Method

  • Synthetic structure
  • Standardized charts

Analysts

Hugo Schott

chargé d'études économiques, Xerfi

Hugo Schott

Hugo Schott logo 1 Hugo Schott logo 2
Mathieu Luinaud

Associate Consultant

Mathieu Luinaud

Mathieu Luinaud logo 1 Mathieu Luinaud logo 2
Education Formation
Robin C.

PhD Industrial transformations

Robin C.

Robin C. logo 1 Robin C. logo 2
Pierre D.

Analyst

Pierre D.

Pierre D. logo 1 Pierre D. logo 2
Arnaud W.
Linkedin logo

Ross Alumni Club France

Arnaud W.

Arnaud W. logo 1 Arnaud W. logo 2
Amaury de Balincourt
Linkedin logo

Analyste de marché chez Businesscoot

Amaury de Balincourt

Amaury de Balincourt logo 1 Amaury de Balincourt logo 2
Pierrick C.

Consultant

Pierrick C.

Pierrick C. logo 1 Pierrick C. logo 2
Maelle V.

Project Finance Analyst, Consulting

Maelle V.

Héloise Fruchard

Etudiante en Double-Diplôme Ingénieur-Manager Centrale

Héloise Fruchard

Héloise Fruchard logo 1 Héloise Fruchard logo 2
Imane Essadiq

EDHEC

Imane Essadiq

Imane Essadiq logo 1 Imane Essadiq logo 2
Vincent D.

Auditeur

Vincent D.

Vincent D. logo 1 Vincent D. logo 2
Eva-Garance T.

Eva-Garance T.

Eva-Garance T. logo 1 Eva-Garance T. logo 2
Michela G.

Market Research Analyst

Michela G.

Michela G. logo 1 Michela G. logo 2
Azelie P.

Market Research Analyst @Businesscoot

Azelie P.

Azelie P. logo 1 Azelie P. logo 2
Cantiane G.

Market Research Analyst @Businesscoot

Cantiane G.

Cantiane G. logo 1 Cantiane G. logo 2
Jules D.

Consultant

Jules D.

Jules D. logo 1 Jules D. logo 2
Alexia V.

Alexia V.

Emil Ohlsson

Emil Ohlsson

Anna O.

Anna O.

Gabriel S.

Gabriel S.